Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs. IV Insulin Glucose Disposal in Type 1 Diabetes
NCT00315952Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Apr 2006
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Technosphere insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by University of Pittsburgh. Primary endpoint: Positron Emission Tomography (PET) imaging of [18F]-fluoro-deoxy-glucose (FDG) uptake by muscle. Started Apr 2006; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00315952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315952.